New Age Alpha Advisors LLC acquired a new position in shares of H.B. Fuller (NYSE:FUL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 6,884 shares of the specialty chemicals company's stock, valued at approximately $465,000.
Several other large investors also recently made changes to their positions in the stock. Amundi increased its holdings in H.B. Fuller by 191.9% during the fourth quarter. Amundi now owns 28,553 shares of the specialty chemicals company's stock worth $1,804,000 after buying an additional 18,771 shares during the last quarter. Lord Abbett & CO. LLC increased its stake in shares of H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company's stock worth $57,952,000 after purchasing an additional 324,056 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company's stock worth $37,448,000 after purchasing an additional 81,558 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company's stock valued at $99,939,000 after purchasing an additional 18,734 shares during the period. Finally, Jones Financial Companies Lllp lifted its stake in H.B. Fuller by 128.8% in the 4th quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company's stock valued at $61,000 after purchasing an additional 506 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company's stock.
Insider Activity
In related news, CEO Celeste Beeks Mastin bought 3,500 shares of the business's stock in a transaction on Tuesday, April 1st. The shares were purchased at an average price of $56.66 per share, for a total transaction of $198,310.00. Following the completion of the transaction, the chief executive officer now directly owns 3,500 shares of the company's stock, valued at approximately $198,310. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 1.99% of the company's stock.
Analyst Upgrades and Downgrades
FUL has been the topic of several research analyst reports. JPMorgan Chase & Co. dropped their price objective on H.B. Fuller from $60.00 to $50.00 and set an "underweight" rating on the stock in a research note on Friday, March 28th. Seaport Res Ptn downgraded H.B. Fuller from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Citigroup reduced their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating for the company in a research report on Friday, January 3rd. Deutsche Bank Aktiengesellschaft cut their target price on shares of H.B. Fuller from $75.00 to $72.00 and set a "buy" rating for the company in a research note on Wednesday, January 22nd. Finally, Vertical Research downgraded shares of H.B. Fuller from a "buy" rating to a "hold" rating in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $63.33.
View Our Latest Research Report on FUL
H.B. Fuller Price Performance
Shares of NYSE FUL traded down $1.68 during midday trading on Friday, reaching $52.66. The company's stock had a trading volume of 635,755 shares, compared to its average volume of 363,695. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The company has a market cap of $2.85 billion, a P/E ratio of 22.80, a P/E/G ratio of 1.13 and a beta of 1.27. The business's 50 day moving average price is $57.65 and its two-hundred day moving average price is $67.72. H.B. Fuller has a fifty-two week low of $51.16 and a fifty-two week high of $87.67.
H.B. Fuller (NYSE:FUL - Get Free Report) last released its earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.05. The company had revenue of $788.66 million for the quarter, compared to analyst estimates of $769.55 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. H.B. Fuller's quarterly revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.67 EPS. On average, analysts forecast that H.B. Fuller will post 4.07 EPS for the current fiscal year.
H.B. Fuller Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Thursday, February 6th were paid a $0.2225 dividend. The ex-dividend date of this dividend was Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a yield of 1.69%. H.B. Fuller's dividend payout ratio (DPR) is 44.50%.
H.B. Fuller Profile
(
Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
See Also

Before you consider H.B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H.B. Fuller wasn't on the list.
While H.B. Fuller currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.